{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:39:04Z","timestamp":1793093944987,"version":"4.5.0"},"publisher-location":"Cham","reference-count":60,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030602031","type":"print"},{"value":"9783030602048","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-60204-8_2","type":"book-chapter","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T11:12:58Z","timestamp":1610104378000},"page":"19-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Peroxisomal Dysfunction and Oxidative Stress in Neurodegenerative Disease: A Bidirectional Crosstalk"],"prefix":"10.1007","author":[{"given":"Marc","family":"Fransen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia","family":"Revenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celien","family":"Lismont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul P.","family":"Van Veldhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,9]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00418-018-1722-5","volume":"150","author":"M Islinger","year":"2018","unstructured":"Islinger M, Voelkl A, Fahimi HD et al (2018) The peroxisome: an update on mysteries 2.0. Histochem Cell Biol 150:443\u2013471","journal-title":"Histochem Cell Biol"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1194\/jlr.R005959","volume":"51","author":"PP Van Veldhoven","year":"2010","unstructured":"Van Veldhoven PP (2010) Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J Lipid Res 51:2863\u20132895","journal-title":"J Lipid Res"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"E3673","DOI":"10.3390\/ijms20153673","volume":"20","author":"C Lismont","year":"2019","unstructured":"Lismont C, Revenco I, Fransen M (2019) Peroxisomal hydrogen peroxide metabolism and signaling in health and disease. Int J Mol Sci 20:E3673","journal-title":"Int J Mol Sci"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fcell.2015.00035","volume":"3","author":"C Lismont","year":"2015","unstructured":"Lismont C, Nordgren M, Van Veldhoven PP et al (2015) Redox interplay between mitochondria and peroxisomes. Front Cell Dev Biol 3:35","journal-title":"Front Cell Dev Biol"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"E3877","DOI":"10.3390\/ijms20163877","volume":"20","author":"F Di Cara","year":"2019","unstructured":"Di Cara F, Andreoletti P, Trompier D et al (2019) Peroxisomes in immune response and inflammation. Int J Mol Sci 20:E3877","journal-title":"Int J Mol Sci"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"E1126","DOI":"10.3390\/ijms18061126","volume":"18","author":"M Fransen","year":"2017","unstructured":"Fransen M, Lismont C, Walton P (2017) The peroxisome-mitochondria connection: how and why? Int J Mol Sci 18:E1126","journal-title":"Int J Mol Sci"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-4939-6937-1_2","volume":"1595","author":"MJ Sch\u00f6nenberger","year":"2017","unstructured":"Sch\u00f6nenberger MJ, Kovacs WJ (2017) Isolation of peroxisomes from mouse brain using a continuous Nycodenz gradient: a comparison to the isolation of liver and kidney peroxisomes. Methods Mol Biol 1595:13\u201326","journal-title":"Methods Mol Biol"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/j.febslet.2011.05.032","volume":"585","author":"CM Kassmann","year":"2011","unstructured":"Kassmann CM, Quintes S, Rietdorf J et al (2011) A role for myelin-associated peroxisomes in maintaining paranodal loops and axonal integrity. FEBS Lett 585:2205\u20132211","journal-title":"FEBS Lett"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.bbamcr.2015.12.005","volume":"1863","author":"J Berger","year":"2016","unstructured":"Berger J, Dorninger F, Forss-Petter S et al (2016) Peroxisomes in brain development and function. Biochim Biophys Acta 1863:934\u2013955","journal-title":"Biochim Biophys Acta"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fphys.2013.00335","volume":"4","author":"PP Van Veldhoven","year":"2013","unstructured":"Van Veldhoven PP, Baes M (2013) Peroxisome-deficient invertebrate and vertebrate animal models. Front Physiol 4:335","journal-title":"Front Physiol"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.redox.2018.01.008","volume":"15","author":"JN Cobley","year":"2018","unstructured":"Cobley JN, Fiorello ML, Bailey DM (2018) 13 reasons why the brain is susceptible to oxidative stress. Redox Biol 15:490\u2013503","journal-title":"Redox Biol"},{"key":"2_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2105607","volume":"2019","author":"G Cenini","year":"2019","unstructured":"Cenini G, Lloret A, Cascella R (2019) Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view. Oxidative Med Cell Longev 2019:2105607","journal-title":"Oxidative Med Cell Longev"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"D800","DOI":"10.1093\/nar\/gkp935","volume":"38","author":"A Schl\u00fcter","year":"2010","unstructured":"Schl\u00fcter A, Real-Chicharro A, Gabald\u00f3n T et al (2010) PeroxisomeDB 2.0: an integrative view of the global peroxisomal metabolome. Nucleic Acids Res 38:D800\u2013D805","journal-title":"Nucleic Acids Res"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.mcp.2018.02.001","volume":"40","author":"RJA Wanders","year":"2018","unstructured":"Wanders RJA (2018) Peroxisomal disorders: improved laboratory diagnosis, new defects and the complicated route to treatment. Mol Cell Probes 40:60\u201369","journal-title":"Mol Cell Probes"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/1873-3468.12788","volume":"591","author":"F Dorninger","year":"2017","unstructured":"Dorninger F, Forss-Petter S, Berger J (2017) From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system. FEBS Lett 591:2761\u20132788","journal-title":"FEBS Lett"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1093\/hmg\/dds097","volume":"21","author":"A Brodde","year":"2012","unstructured":"Brodde A, Teigler A, Brugger B et al (2012) Impaired neurotransmission in ether lipid-deficient nerve terminals. Hum Mol Genet 21:2713\u20132724","journal-title":"Hum Mol Genet"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.14336\/AD.2015.0823","volume":"7","author":"P Sch\u00f6nfeld","year":"2016","unstructured":"Sch\u00f6nfeld P, Reiser G (2016) Brain lipotoxicity of phytanic acid and very long-chain fatty acids. Harmful cellular\/mitochondrial activities in Refsum disease and X-linked adrenoleukodystrophy. Aging Dis 7:136\u2013149","journal-title":"Aging Dis"},{"key":"2_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/623257","volume":"2012","author":"A Zarrouk","year":"2012","unstructured":"Zarrouk A, Vejux A, Nury T et al (2012) Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E). Oxidative Med Cell Longev 2012:623257","journal-title":"Oxidative Med Cell Longev"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s12311-014-0593-0","volume":"13","author":"EN Busanello","year":"2014","unstructured":"Busanello EN, Lobato VG, Zanatta \u00c2 et al (2014) Pristanic acid provokes lipid, protein, and DNA oxidative damage and reduces the antioxidant defenses in cerebellum of young rats. Cerebellum 13:751\u2013759","journal-title":"Cerebellum"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.brainres.2011.01.014","volume":"1382","author":"G Leipnitz","year":"2011","unstructured":"Leipnitz G, Amaral AU, Fernandes CG et al (2011) Pristanic acid promotes oxidative stress in brain cortex of young rats: a possible pathophysiological mechanism for brain damage in peroxisomal disorders. Brain Res 1382:259\u2013265","journal-title":"Brain Res"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neuroscience.2015.07.028","volume":"304","author":"CG Borges","year":"2015","unstructured":"Borges CG, Canani CR, Fernandes CG et al (2015) Reactive nitrogen species mediate oxidative stress and astrogliosis provoked by in vivo administration of phytanic acid in cerebellum of adolescent rats: a potential contributing pathomechanism of cerebellar injury in peroxisomal disorders. Neuroscience 304:122\u2013132","journal-title":"Neuroscience"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/bpa.12290","volume":"25","author":"S De Munter","year":"2015","unstructured":"De Munter S, Verheijden S, R\u00e9gal L et al (2015) Peroxisomal disorders: a review on cerebellar pathologies. Brain Pathol 25:663\u2013678","journal-title":"Brain Pathol"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/BF00711689","volume":"16","author":"HJ ten Brink","year":"1993","unstructured":"ten Brink HJ, van den Heuvel CM, Poll-The BT et al (1993) Peroxisomal disorders: concentrations of metabolites in cerebrospinal fluid compared with plasma. J Inherit Metab Dis 16:587\u2013590","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl 1","key":"2_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF00711428","volume":"18","author":"NM Verhoeven","year":"1995","unstructured":"Verhoeven NM, Kulik W, van den Heuvel CM et al (1995) Pre- and postnatal diagnosis of peroxisomal disorders using stable-isotope dilution gas chromatography--mass spectrometry. J Inherit Metab Dis 18(Suppl 1):45\u201360","journal-title":"J Inherit Metab Dis"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuroscience.2016.08.001","volume":"334","author":"RS Rahim","year":"2016","unstructured":"Rahim RS, Chen M, Nourse CC et al (2016) Mitochondrial changes and oxidative stress in a mouse model of Zellweger syndrome neuropathogenesis. Neuroscience 334:201\u2013213","journal-title":"Neuroscience"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1242\/dmm.007708","volume":"5","author":"B Ahlemeyer","year":"2012","unstructured":"Ahlemeyer B, Gottwald M, Baumgart-Vogt E (2012) Deletion of a single allele of the Pex11\u03b2 gene is sufficient to cause oxidative stress, delayed differentiation and neuronal death in mouse brain. Dis Model Mech 5:125\u2013140","journal-title":"Dis Model Mech"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1742-2094-9-61","volume":"9","author":"A Bottelbergs","year":"2012","unstructured":"Bottelbergs A, Verheijden S, Van Veldhoven PP et al (2012) Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system. J Neuroinflammation 9:61","journal-title":"J Neuroinflammation"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10571-015-0234-2","volume":"36","author":"M Deon","year":"2016","unstructured":"Deon M, Marchetti DP, Donida B et al (2016) Oxidative stress in patients with X-linked adrenoleukodystrophy. Cell Mol Neurobiol 36:497\u2013512","journal-title":"Cell Mol Neurobiol"},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/ncpneuro0421","volume":"3","author":"HW Moser","year":"2007","unstructured":"Moser HW, Mahmood A, Raymond GV (2007) X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 3:140\u2013151","journal-title":"Nat Clin Pract Neurol"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"e8604","DOI":"10.15252\/emmm.201708604","volume":"10","author":"P Ranea-Robles","year":"2018","unstructured":"Ranea-Robles P, Launay N, Ruiz M et al (2018) Aberrant regulation of the GSK-3\u03b2\/NRF2 axis unveils a novel therapy for adrenoleukodystrophy. EMBO Mol Med 10:e8604","journal-title":"EMBO Mol Med"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1750-3639.2010.00392.x","volume":"20","author":"I Singh","year":"2010","unstructured":"Singh I, Pujol A (2010) Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis. Brain Pathol 20:838\u2013844","journal-title":"Brain Pathol"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jsbmb.2016.03.037","volume":"169","author":"T Nury","year":"2017","unstructured":"Nury T, Zarrouk A, Ragot K et al (2017) 7-Ketocholesterol is increased in the plasma of X-ALD patients and induces peroxisomal modifications in microglial cells: potential roles of 7-ketocholesterol in the pathophysiology of X-ALD. J Steroid Biochem Mol Biol 169:123\u2013136","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12272-019-01131-2","volume":"42","author":"DS Jo","year":"2019","unstructured":"Jo DS, Cho DH (2019) Peroxisomal dysfunction in neurodegenerative diseases. Arch Pharm Res 42:393\u2013406","journal-title":"Arch Pharm Res"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"E3896","DOI":"10.3390\/ijms20163896","volume":"20","author":"E L\u00e9vy","year":"2019","unstructured":"L\u00e9vy E, El Banna N, Ba\u00eflle D et al (2019) Causative links between protein aggregation and oxidative stress: a review. Int J Mol Sci 20:E3896","journal-title":"Int J Mol Sci"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1073\/pnas.1114639109","volume":"109","author":"J Sasabe","year":"2012","unstructured":"Sasabe J, Miyoshi Y, Suzuki M et al (2012) D-amino acid oxidase controls motoneuron degeneration through D-serine. Proc Natl Acad Sci U S A 109:627\u2013632","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR36","doi-asserted-by":"crossref","unstructured":"Wojsiat J, Zoltowska KM, Laskowska-Kaszub K et al. (2018) Oxidant\/antioxidant imbalance in Alzheimer\u2019s disease: therapeutic and diagnostic prospects. Oxidative Med Cell Longev 2018:6435861","DOI":"10.1155\/2018\/6435861"},{"key":"2_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/967203","volume":"2015","author":"S Porcellotti","year":"2015","unstructured":"Porcellotti S, Fanelli F, Fracassi A et al (2015) Oxidative stress during the progression of \u03b2-amyloid pathology in the neocortex of the Tg2576 mouse model of Alzheimer\u2019s disease. Oxidative Med Cell Longev 2015:967203","journal-title":"Oxidative Med Cell Longev"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00401-011-0836-9","volume":"122","author":"J Kou","year":"2011","unstructured":"Kou J, Kovacs GG, H\u00f6ftberger R et al (2011) Peroxisomal alterations in Alzheimer\u2019s disease. Acta Neuropathol 122:271\u2013283","journal-title":"Acta Neuropathol"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3233\/JAD-2011-101608","volume":"24","author":"M Igarashi","year":"2011","unstructured":"Igarashi M, Ma K, Gao F et al (2011) Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer\u2019s disease prefrontal cortex. J Alzheimers Dis 24:507\u2013517","journal-title":"J Alzheimers Dis"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neuroscience.2015.11.067","volume":"315","author":"Y Shi","year":"2016","unstructured":"Shi Y, Sun X, Sun Y et al (2016) Elevation of cortical C26:0 due to the decline of peroxisomal \u03b2-oxidation potentiates amyloid \u03b2 generation and spatial memory deficits via oxidative stress in diabetic rats. Neuroscience 315:125\u2013135","journal-title":"Neuroscience"},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3233\/JAD-2012-120397","volume":"33","author":"NC Inestrosa","year":"2013","unstructured":"Inestrosa NC, Carvajal FJ, Zolezzi JM et al (2013) Peroxisome proliferators reduce spatial memory impairment, synaptic failure, and neurodegeneration in brains of a double transgenic mice model of Alzheimer\u2019s disease. J Alzheimers Dis 33:941\u2013959","journal-title":"J Alzheimers Dis"},{"key":"2_CR42","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/bpa.12368","volume":"27","author":"HJ Nell","year":"2016","unstructured":"Nell HJ, Au JL, Giordano CR et al (2016) Targeted antioxidant, catalase-SKL, reduces beta-amyloid toxicity in the rat brain. Brain Pathol 27:86\u201394","journal-title":"Brain Pathol"},{"key":"2_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/ejn.14264","volume":"49","author":"A Bose","year":"2019","unstructured":"Bose A, Beal MF (2019) Mitochondrial dysfunction and oxidative stress in induced pluripotent stem cell models of Parkinson\u2019s disease. Eur J Neurosci 49:525\u2013532","journal-title":"Eur J Neurosci"},{"key":"2_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neurobiolaging.2016.08.027","volume":"49","author":"R Marin","year":"2017","unstructured":"Marin R, Fabelo N, Mart\u00edn V et al (2017) Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer\u2019s and Parkinson\u2019s diseases. Neurobiol Aging 49:52\u201359","journal-title":"Neurobiol Aging"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00401-007-0264-z","volume":"114","author":"K Suzuki","year":"2007","unstructured":"Suzuki K, Iseki E, Togo T et al (2007) Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses. Acta Neuropathol 114:481\u2013489","journal-title":"Acta Neuropathol"},{"key":"2_CR46","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jnr.22246","volume":"88","author":"E Yakunin","year":"2010","unstructured":"Yakunin E, Moser A, Loeb V et al (2010) Alpha-synuclein abnormalities in mouse models of peroxisome biogenesis disorders. J Neurosci Res 88:866\u2013876","journal-title":"J Neurosci Res"},{"key":"2_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1750-3639.2011.00530.x","volume":"22","author":"E Yakunin","year":"2012","unstructured":"Yakunin E, Loeb V, Kisos H et al (2012) \u0391-synuclein neuropathology is controlled by nuclear hormone receptors and enhanced by docosahexaenoic acid in a mouse model for Parkinson\u2019s disease. Brain Pathol 22:280\u2013294","journal-title":"Brain Pathol"},{"key":"2_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/acn3.38","volume":"1","author":"E Yakunin","year":"2014","unstructured":"Yakunin E, Kisos H, Kulik W et al (2014) The regulation of catalase activity by PPAR \u03b3 is affected by \u03b1-synuclein. Ann Clin Transl Neurol 1:145\u2013159","journal-title":"Ann Clin Transl Neurol"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1021\/acschemneuro.8b00180","volume":"10","author":"P Rane","year":"2019","unstructured":"Rane P, Sarmah D, Bhute S et al (2019) Novel targets for Parkinson\u2019s disease: addressing different therapeutic paradigms and conundrums. ACS Chem Neurosci 10:44\u201357","journal-title":"ACS Chem Neurosci"},{"key":"2_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151020","volume":"11","author":"E Miville-Godbout","year":"2016","unstructured":"Miville-Godbout E, Bourque M, Morissette M et al (2016) Plasmalogen augmentation reverses striatal dopamine loss in MPTP mice. PLoS One 11:e0151020","journal-title":"PLoS One"},{"key":"2_CR51","doi-asserted-by":"crossref","unstructured":"Faissner S, Plemel JR, Gold R et al (2019) Progressive multiple sclerosis: from pathophysiology to therapeutic strategies. Nat Rev Drug Discov 18:905\u2013922","DOI":"10.1038\/s41573-019-0035-2"},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/1352458513505691","volume":"20","author":"E Gray","year":"2014","unstructured":"Gray E, Rice C, Hares K et al (2014) Reductions in neuronal peroxisomes in multiple sclerosis grey matter. Mult Scler 20:651\u2013659","journal-title":"Mult Scler"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2004.06.059","volume":"1022","author":"I Singh","year":"2004","unstructured":"Singh I, Paintlia AS, Khan M et al (2004) Impaired peroxisomal function in the central nervous system with inflammatory disease of experimental autoimmune encephalomyelitis animals and protection by lovastatin treatment. Brain Res 1022:1\u201311","journal-title":"Brain Res"},{"key":"2_CR54","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/imm.12893","volume":"154","author":"I Singh","year":"2018","unstructured":"Singh I, Samuvel DJ, Choi S et al (2018) Combination therapy of lovastatin and AMP-activated protein kinase activator improves mitochondrial and peroxisomal functions and clinical disease in experimental autoimmune encephalomyelitis model. Immunology 154:434\u2013451","journal-title":"Immunology"},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neulet.2017.05.008","volume":"651","author":"L Szalardy","year":"2017","unstructured":"Szalardy L, Zadori D, Bencsik K et al (2017) Unlike PPARgamma, neither other PPARs nor PGC-1alpha is elevated in the cerebrospinal fluid of patients with multiple sclerosis. Neurosci Lett 651:128\u2013133","journal-title":"Neurosci Lett"},{"key":"2_CR56","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1471-4159.2012.07934.x","volume":"123","author":"H Gonzalo","year":"2012","unstructured":"Gonzalo H, Brieva L, Tatzber F et al (2012) Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism. J Neurochem 123:622\u2013634","journal-title":"J Neurochem"},{"key":"2_CR57","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1523\/JNEUROSCI.3941-15.2017","volume":"37","author":"MS Hossain","year":"2017","unstructured":"Hossain MS, Abe Y, Ali F et al (2017) Reduction of ether-type glycerophospholipids, plasmalogens, by NF-\u03baB signal leading to microglial activation. J Neurosci 37:4074\u20134092","journal-title":"J Neurosci"},{"key":"2_CR58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/ars.2014.5833","volume":"22","author":"JM Young","year":"2015","unstructured":"Young JM, Nelson JW, Cheng J et al (2015) Peroxisomal biogenesis in ischemic brain. Antioxid Redox Signal 22:109\u2013120","journal-title":"Antioxid Redox Signal"},{"key":"2_CR59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mcn.2017.11.014","volume":"86","author":"JF Moruno-Manchon","year":"2018","unstructured":"Moruno-Manchon JF, Uzor NE, Kesler SR et al (2018) Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy. Mol Cell Neurosci 86:65\u201371","journal-title":"Mol Cell Neurosci"},{"key":"2_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17121973","volume":"17","author":"M Debbabi","year":"2016","unstructured":"Debbabi M, Nury T, Zarrouk A et al (2016) Protective effects of \u03b1-tocopherol, \u03b3-tocopherol and oleic acid, three compounds of olive oils, and no effect of Trolox, on 7-ketocholesterol-induced mitochondrial and peroxisomal dysfunction in microglial BV-2 cells. Int J Mol Sci 17:E1973","journal-title":"Int J Mol Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Peroxisome Biology: Experimental Models, Peroxisomal Disorders and Neurological Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-60204-8_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T02:34:31Z","timestamp":1724294071000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-60204-8_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030602031","9783030602048"],"references-count":60,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-60204-8_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"9 January 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}